I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
De Pizzol, Maria
270
results:
Search for persons
X
Format
Online (270)
Mediatypes
Articles (Online) (90)
Bookchapter (Online) (2)
OpenAccess-fulltext (178)
Languages
english (161)
portuguese (79)
Sorted by: Relevance
Sorted by: Year
?
1
A Multicenter Phase 2 Randomized Controlled Study on the Ef..:
Landoni, Giovanni
;
Piemonti, Lorenzo
;
Monforte, Antonella d'Arminio
...
Infectious Diseases and Therapy. , 2022
Link:
https://doi.org/10.1007/..
?
2
A phase 2 randomized, double-blinded, placebo-controlled, m..:
Nicastri, Emanuele
;
Marinangeli, Franco
;
Pivetta, Emanuele
...
eClinicalMedicine. 48 (2022) - p. 101450 , 2022
Link:
https://doi.org/10.1016/..
?
3
CXCR1/2 dual-inhibitor ladarixin reduces tumour burden and ..:
Piro, Geny
;
Carbone, Carmine
;
Agostini, Antonio
...
British Journal of Cancer. 128 (2022) 2 - p. 331-341 , 2022
Link:
https://doi.org/10.1038/..
?
4
CXCR1 and CXCR2 Chemokine Receptor Agonists Produced by Tum..:
Teijeira, Álvaro
;
Garasa, Saray
;
Gato, María
...
Immunity. 52 (2020) 5 - p. 856-871.e8 , 2020
Link:
https://doi.org/10.1016/..
?
5
Ladarixin, a dual CXCR1/2 inhibitor, attenuates experimenta..:
Kemp, Daria Marley
;
Pidich, Alyson
;
Larijani, Mary
...
Oncotarget. 8 (2017) 9 - p. 14428-14442 , 2017
Link:
https://doi.org/10.18632..
?
6
Multiple anti-tumor effects of Reparixin on thyroid cancer:
Liotti, Federica
;
De Pizzol, Maria
;
Allegretti, Marcello
..
Oncotarget. 8 (2017) 22 - p. 35946-35961 , 2017
Link:
https://doi.org/10.18632..
?
7
Targeting CXCR1 on breast cancer stem cells: signaling path..:
Brandolini, Laura
;
Cristiano, Loredana
;
Fidoamore, Alessia
...
Oncotarget. 6 (2015) 41 - p. 43375-43394 , 2015
Link:
https://doi.org/10.18632..
?
8
Expression of the α7 nAChR subunit duplicate form (CHRFAM7A..:
Benfante, Roberta
;
Antonini, Ruth Adele
;
De Pizzol, Maria
...
Journal of Neuroimmunology. 230 (2011) 1-2 - p. 74-84 , 2011
Link:
https://doi.org/10.1016/..
?
9
A glimpse on the phenomenon of macrophage polarization duri..:
Pello, Oscar M.
;
Silvestre, Carlos
;
De Pizzol, Maria
.
Immunobiology. 216 (2011) 11 - p. 1172-1176 , 2011
Link:
https://doi.org/10.1016/..
?
10
Differential regulation of iron homeostasis during human ma..:
Recalcati, Stefania
;
Locati, Massimo
;
Marini, Agnese
...
European Journal of Immunology. 40 (2010) 3 - p. 824-835 , 2010
Link:
https://doi.org/10.1002/..
?
11
Efficacy and Safety of Reparixin in Patients with Severe CO..:
Piemonti, Lorenzo
;
Landoni, Giovanni
;
Voza, Antonio
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600076/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
12
Efficacy and Safety of Reparixin in Patients with Severe CO..:
Piemonti, Lorenzo
;
Landoni, Giovanni
;
Voza, Antonio
...
info:eu-repo/semantics/altIdentifier/pmid/37798468. , 2023
Link:
https://hdl.handle.net/1..
?
13
Efficacy and safety of reparixin in patients with severe co..:
Piemonti, Lorenzo
;
Landoni, Giovanni
;
Voza, Antonio
...
info:eu-repo/semantics/altIdentifier/pmid/37798468. , 2023
Link:
https://hdl.handle.net/1..
?
14
Efficacy and Safety of Reparixin in Patients with Severe CO..:
Piemonti, Lorenzo
;
Landoni, Giovanni
;
Voza, Antonio
...
info:eu-repo/semantics/altIdentifier/pmid/37798468. , 2023
Link:
https://hdl.handle.net/2..
?
15
A multicenter phase 2 randomized controlled study on the ef..:
Landoni, Giovanni
;
Piemonti, Lorenzo
;
D'Arminio Monforte, Antonella
...
info:eu-repo/semantics/altIdentifier/pmid/35618953. , 2022
Link:
http://hdl.handle.net/24..
1-15